Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. - Test2 - elhamkhani - TriplyDB

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

http://www.wikidata.org/entity/Q34027039

about

Hepatosplanchnic circulation in cirrhosis and sepsis Model for End-stage Liver Disease Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study.The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study.The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.Elevation of HO-1 Expression Mitigates Intestinal Ischemia-Reperfusion Injury and Restores Tight Junction Function in a Rat Liver Transplantation Model.Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.Liver transplantation in adults: Choosing the appropriate timing High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome.Introducing an optimal liver allocation system for liver cirrhosis patients Pretransplant Factors and Associations with Postoperative Respiratory Failure, ICU Length of Stay, and Short-Term Survival after Liver Transplantation in a High MELD Population.Association of intraoperative transfusion of blood products with mortality in lung transplant recipients.Influence on ICU course, outcome and costs for lung transplantation after implementation of the new Swiss transplantation law.Critical care of the end-stage liver disease patient awaiting liver transplantation.Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.MELD score as a predictor of mortality, length of hospital stay, and disease burden: A single-center retrospective study in 39,323 inpatients.High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.LIPID PROFILE OF CIRRHOTIC PATIENTS AND ITS ASSOCIATION WITH PROGNOSTIC SCORES: a cross-sectional study.Is MELD score failing patients with liver disease and hepatorenal syndrome?Hepatobiliary quiz-6 (2013).Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation.Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation.Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality.Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥40: a retrospective cohort study

P2860

Q26864350-B9A4DF78-D073-46B7-AFDE-B81DE590709C Q26864971-9CB225FF-8E5A-4B99-855D-8918B2AC69B8 Q33752313-8679836F-CE1D-45DD-BC03-769B33E9D462 Q34587152-442FC7AF-BF33-4D79-A4C9-543A727E9339 Q35257636-F3FF53E1-5F38-43C3-A804-3C0C53E1544B Q35639466-F0B8A21A-B331-4739-A8DD-1040161C121D Q35647592-15D5B744-4305-4496-84AA-05DCE092ED0D Q35908250-0CD687B1-9F45-4FE1-9F4B-7B1CB3C57DB2 Q36197511-6DC7B285-C137-4C48-B3A6-01A0BDD64777 Q36220176-4508F154-0C61-4B41-9D1B-6D72ED784BF3 Q36314800-B6B01C86-A414-4721-8127-CD100344B5AF Q37208965-C5D02EDC-7F4B-4475-A2C1-361D58EEE28D Q37459818-0E92B14B-7406-44FD-A8AE-8449A57AB44F Q37660513-B8DC769E-ED2E-4721-A2CD-8C25CD909C68 Q37683835-F7139C48-BACB-4202-A429-9B98B8B4BC62 Q37867071-EAAD55AC-6C1B-4822-A172-506DB004650D Q38453564-4E3D7B33-5C7A-46FE-9473-B68C6D26C4DF Q40160296-79AB0062-EAB2-41F4-896B-8996C2FB27C5 Q40204376-17FE121A-EF27-4FAA-BCE5-084F9DF49A6C Q40943348-7FE814D9-A8AB-4AFF-99E9-0D32C89DF180 Q41189039-A4C0DD12-957A-4675-B10C-B7AF4EC824AD Q41258370-3E13CD0C-77AA-4266-BCCA-842D64EBC094 Q48207912-4905472B-8350-49F4-B77F-C7EA74EF49E1 Q51346002-975A90DC-2C7A-42B6-96FA-59AB74A8A1B5 Q51798512-0234C465-63D9-4F45-AC00-84FEC6476F9A Q59322992-1CA00662-0268-4C3D-8CCA-6877BEC1077B

P2860

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

http://www.wikidata.org/entity/Q34027039

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Model of end stage liver disea ...... n liver transplant recipients.

@ast

Model of end stage liver disea ...... n liver transplant recipients.

@en

Model of end stage liver disease

@nl

type

label

Model of end stage liver disea ...... n liver transplant recipients.

@ast

Model of end stage liver disea ...... n liver transplant recipients.

@en

Model of end stage liver disease

@nl

prefLabel

Model of end stage liver disea ...... n liver transplant recipients.

@ast

Model of end stage liver disea ...... n liver transplant recipients.

@en

Model of end stage liver disease

@nl

P1433

Q34027039-8E8AEF35-70AB-4493-8F7B-7C006D41BCF7

P1476

Q34027039-4F8A1E38-BA35-4405-8B64-5DBC3688D3B9

P2093

Q34027039-5E55D47D-6385-413F-BA5E-C57EE710E71C

Q34027039-AEFCF356-8F6F-400F-AA12-98DECA973D50

Q34027039-BDABCE7F-6AA2-41E6-92C1-3D719C172FA2

Q34027039-C058BB2C-D4F5-4D94-9EB9-8F101356E641

Q34027039-CD1C8FCE-5539-4E16-811F-01B9ADC62EBC

Q34027039-FEC4C040-A728-46B2-AF49-023D1F8E4CD7

P2860

Q34027039-0F4FF404-02A5-42D7-98B0-7F53FB9447D3

Q34027039-168FF4AA-7B60-4443-9905-4425048D5AC3

Q34027039-1F6478F9-F289-4FBC-8CB2-92001545A90D

Q34027039-20652B9D-6989-48BD-816F-3A0955A058DC

Q34027039-2B1D4D8F-35B4-4549-9ED3-1AB977E49FCF

Q34027039-2BBF6122-053E-4855-897B-2BC0A5B445D2

Q34027039-2C5ED34F-76DC-443E-8A32-A270E477CB23

Q34027039-38CD993C-21B1-4515-B26A-A04E901FEA3B

Q34027039-3AA53799-A495-4E1A-9512-B4544C2433D2

Q34027039-3B9B938C-356C-4300-B9D3-66885B4697C6

P2888

Q34027039-34038EC7-A7A5-445C-97B3-E5A73314DDFD

P304

Q34027039-A660DB46-0491-4564-BC16-064FD7E6A66B

P31

Q34027039-2C1083C2-A7DA-4C05-A936-8CA83C01720A

P356

Q34027039-CAF1175E-03F3-4C36-A956-E6C0AB1F26E4

P433

Q34027039-382E3B43-E5C0-4023-8D1F-CA6829BC7210

P478

Q34027039-F8518B77-2180-47C7-ABBA-3B61ED9D4E4D

P50

Q34027039-36B6010B-DFAA-421B-BDA7-9B8DCDF33CE3

P577

Q34027039-C3713BFB-F09A-4E8E-BBEA-A218970BDE42

P5875

Q34027039-14F98259-095E-457D-8F94-1510244F8B54

P698

Q34027039-E9F4A8BF-8492-45E3-93D1-5D6B3F9CDB58

P932

Q34027039-996C6217-6CAA-4D33-89CC-1B67EACF0412

P356

P1433

P1476

Model of end stage liver disea ...... n liver transplant recipients.

@en

P2093

Christian E Oberkofler

http://www.w3.org/2001/XMLSchema#string

John F Stover

http://www.w3.org/2001/XMLSchema#string

Markus Béchir

http://www.w3.org/2001/XMLSchema#string

Philipp Dutkowski

http://www.w3.org/2001/XMLSchema#string

Reto A Schuepbach

http://www.w3.org/2001/XMLSchema#string

Reto Stocker

http://www.w3.org/2001/XMLSchema#string

P2860

Methods of preventing bacterial sepsis and wound complications for liver transplantation

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.

Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

MELD score predicts 1-year patient survival post-orthotopic liver transplantation.

Epidemiology of sepsis: an update.

Advantages of venous bypass during orthotopic transplantation of the liver.

Critical care of the liver transplant patient: an update.

The course of type 1 hepato-renal syndrome post liver transplantation.

P2888

P304

R117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC9068

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Alain Clavien

P577

2010-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44675684

http://www.w3.org/2001/XMLSchema#string

P698

20550662

http://www.w3.org/2001/XMLSchema#string

P932

2911764

http://www.w3.org/2001/XMLSchema#string